Language model-guided anticipation and discovery of unknown metabolites
Authors:
Preprint
Abstract
Despite decades of study, large parts of the mammalian metabolome remain unexplored. Mass spectrometry-based metabolomics routinely detects thousands of small molecule-associated peaks within human tissues and biofluids, but typically only a small fraction of these can be identified, and structure elucidation of novel metabolites remains a low-throughput endeavor. Biochemical large language models have transformed the interpretation of DNA, RNA, and protein sequences, but have not yet had a comparable impact on understanding small molecule metabolism. Here, we present an approach that leverages chemical language models to discover previously uncharacterized metabolites. We introduce DeepMet, a chemical language model that learns the latent biosynthetic logic embedded within the structures of known metabolites and exploits this understanding to anticipate the existence of as-of-yet undiscovered metabolites. Prospective chemical synthesis of metabolites predicted to exist by DeepMet directs their targeted discovery. Integrating DeepMet with tandem mass spectrometry (MS/MS) data enables automated metabolite discovery within complex tissues. We harness DeepMet to discover several dozen structurally diverse mammalian metabolites. Our work demonstrates the potential for language models to accelerate the mapping of the metabolome.Keywords
This publication has 83 references indexed in Scilit:
- A metabolomics pipeline highlights microbial metabolism in bloodstream infectionsCell, 2024
- The underappreciated diversity of bile acid modificationsCell, 2024
- (Re‐)use and (re‐)analysis of publicly available metabolomics dataProteomics, 2023
- Learning the protein language: Evolution, structure, and functionCell Systems, 2021
- El-MAVEN: A Fast, Robust, and User-Friendly Mass Spectrometry Data Processing Engine for Metabolomics2019
- Discovery and Identification of an Endogenous Metabolite of Tramiprosate and Its Prodrug ALZ-801 that Inhibits Beta Amyloid Oligomer Formation in the Human BrainCNS Drugs, 2018
- Competitive fragmentation modeling of ESI-MS/MS spectra for putative metabolite identificationMetabolomics, 2014
- Proposed minimum reporting standards for chemical analysisMetabolomics, 2007
- Comparing the chemical spaces of metabolites and available chemicals: models of metabolite-likenessMolecular Diversity, 2007
- Variation in human metabolism of S-carboxymethylcysteineEuropean Journal of Drug Metabolism and Pharmacokinetics, 1980